Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

NCT06864936 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT06864936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06864936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
Lead sponsor
University of Maryland, Baltimore
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2026
Completion date
January 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms) - relapsing-remitting